WebJan 1, 2024 · HighTide Therapeutics General Information. Description. Developer and researcher of innovative drugs designed to treat metabolic and digestive system diseases. The company's drugs target disease biology, medicinal chemistry, regulatory affairs and clinical development to discover treatments for liver, gastrointestinal diseases and … WebJan 26, 2024 · Adcentrx Therapeutics Hong Kong Limited was incorporated on Jan 26 2024 as a private company limited by shares type, The date of annual examination for this private company limited is between Jan 26 and Mar 08 upon the anniversary of incorporation. The company status is Live now. Adcentrx Therapeutics Hong Kong Limited has been …
HighTide Therapeutics (Hong Kong) Limited - Dun & Bradstreet
WebHighTide Therapeutics (Hong Kong) Limited was incorporated on 09-APR-2024 as a Private company limited by shares registered in Hong Kong. It's company registration number is: … WebHightide Therapeutics (hong Kong) Limited has been operatingfor 4 years 11 months, and 25 days. Company Details: Business Name : HighTide Therapeutics (Hong Kong) Limited: Business Number : 2677102: Business Type : Private company limited by shares: Registration Date : 09-APR-2024: Status : Live : invu by tae
HighTide Therapeutics
WebFeb 24, 2024 · 简介: HighTide Therapeutics (Hong Kong) Limited,成立于2024年,位于香港特别行政区。 通过天眼查大数据分析,HighTide Therapeutics (Hong Kong) Limited共 … WebFeb 22, 2024 · /PRNewswire/ -- OBI Pharma, Inc. (OBI), a Taiwan biopharma company (TPEx: 4174), and Odeon Therapeutics (Odeon), a China biopharma company, have entered into... OBI Pharma Enters License... WebJan 18, 2024 · HighTide Therapeutics Limited acquired an unknown stake in Shenzhen Hightide Biopharmaceutical, Ltd from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on January 18, 2024. ... HighTide Therapeutics Limited acquired an unknown stake in Shenzhen Hightide Biopharmaceutical, Ltd from Shenzhen Hepalink Pharmaceutical … invu accounts payable